Philip Hodges, Director at Altimmune, Inc. (ALT), sold 3,727 shares at $13.54 ($47K) on 2020-12-01, disclosed to the SEC on 2020-12-02.
Scheduled sale ($47k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 2,500 | $30K | 64.4% |
| 2 | $13.54 | 1,227 | $17K | 35.6% |
| Total | $12.51 avg | 3,727 | $47K | 100% |